FDA Inspection 1174664 — LFB USA, Inc.
The FDA completed an inspection of LFB USA, Inc. on April 8, 2022 in Charlton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 8, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Charlton, MA (United States)